Formulation for soft anticholinergic analogs
US12357609B2 · kind B2 · utility
0Cited by
27References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 2021 |
| Grant date | Jul 15, 2025 |
| Priority date | — |
| Expiry date | Aug 5, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D207/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.